NAD+ Metabolism

NAD+ Testing & Biomarkers

Written by ReCellence™ Editorial Team, Health Content SpecialistsReviewed by Medical Review Board, MD, PhDLast reviewed: March 8, 2026

Medical Disclaimer: This content is for educational and informational purposes only and is not intended as medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider before making any health-related decisions. If you are experiencing a medical emergency, call your local emergency services immediately.

What This Page Explains

NAD+ testing has become commercially available, but measuring intracellular NAD+ levels accurately presents significant technical challenges. Understanding the limitations of current testing methods is essential for interpreting results.

What If Your Afternoon Energy Crash Isn't About Sleep?

New research points to mitochondrial dysfunction as the hidden driver of chronic fatigue. Here's what you can do about it today.

Detailed Evidence

NAD+ can be measured through several methods: (1) Whole blood NAD+ — reflects circulating levels but not intracellular concentrations; (2) PBMC (peripheral blood mononuclear cell) NAD+ — more representative of intracellular status; (3) Tissue biopsy — gold standard but invasive; (4) Metabolomics panels — measure NAD+ metabolites (NMN, NR, nicotinamide) as proxies. Direct-to-consumer blood tests are available but have limited clinical utility without reference ranges for therapeutic decision-making.

Evidence Hierarchy

Strongest

Systematic Reviews & Meta-Analyses

Multiple high-quality trials combined

Strong

Randomized Controlled Trials (RCTs)

Gold standard for treatment efficacy

Moderate

Observational Studies

Can show associations, not causation

Limited

Case Reports & Expert Opinion

Hypothesis-generating only

Weakest

Preclinical (Lab/Animal) Studies

Should NOT be extrapolated to humans

Exposed: The Cellular Energy Secret Most Doctors Never Mention

It's not a drug. It's not a vitamin. It's a 5-compound cellular renewal protocol backed by peer-reviewed research.

Study Quality Indicators

Higher Quality Indicators

  • Large sample size (hundreds to thousands)
  • Randomized and blinded design
  • Placebo-controlled comparison
  • Published in peer-reviewed journals
  • Replicated in multiple studies
  • Registered trial protocol before starting

Lower Quality Indicators

  • Small sample size (under 100)
  • No control group or blinding
  • Manufacturer-funded with conflicts
  • Only animal/cell studies
  • Never replicated
  • Published in predatory journals

Important Limitations

  • • Supplement research often has methodological limitations
  • • Results from one study may not generalize to all people
  • • Marketing claims often exceed what research supports
  • • Absence of evidence is not evidence of absence
  • • Individual response to supplements varies widely

Quick Answers

Q1.

Can you measure your NAD+ levels?

Yes — NAD+ can be quantified in blood, cells, or tissue, though each method reflects different compartments and has trade-offs.

Q2.

What methods are used to measure NAD+?

Common methods include whole-blood NAD+, PBMC NAD+, tissue biopsy, and metabolomics panels measuring NAD+ and related metabolites via LC-MS/MS.

Q3.

What do NAD+ test results tell you?

They indicate circulating or cellular NAD+ relative to a reference, but lack standardized clinical reference ranges for therapeutic decisions.

Q4.

Are consumer NAD+ tests reliable?

Dried-blood-spot consumer tests have lower analytical accuracy than clinical mass spectrometry and limited clinical utility.

Q5.

What is a normal NAD+ level?

Standardized clinical reference ranges for humans have not been established; reported values vary by method and lab.

Q6.

Should you test NAD+ before supplementing?

Testing is optional; most clinicians rely on symptoms and risk factors since reference ranges for dosing decisions aren't established.

Q7.

What NAD+ metabolites can be tested?

Metabolomics can quantify NAD+, NMN, NR, nicotinamide, NADP+, and related intermediates from a single sample.

Q8.

How is blood NAD+ different from tissue NAD+?

Blood NAD+ may not reflect tissue-specific concentrations in brain, liver, or muscle; tissue biopsy is the gold standard but invasive.

Q9.

Can imaging measure NAD+ in living tissue?

31P-MRS can non-invasively measure the NAD+/NADH ratio in living human brain tissue.

Q10.

What biomarkers correlate with NAD+ levels?

Inflammatory markers CRP and IL-6 are inversely correlated with NAD+ through CD38-mediated degradation.

Q11.

How often should NAD+ be tested?

No guideline exists; researchers typically measure at baseline and after an intervention in trial settings.

Q12.

What are the limitations of NAD+ testing?

NAD+ degrades rapidly in samples, blood may not reflect tissue levels, and standardized clinical reference ranges are lacking.

Q13.

Are there NAD+ at-home test kits?

Yes — dried-blood-spot kits exist, but they have lower accuracy than clinical mass spectrometry and limited interpretive value.

Q14.

What is the NAD+/NADH ratio test?

A measure of cellular redox status reflecting energy state; it can be assayed in blood or via 31P-MRS in tissue.

Q15.

Will NAD+ testing become routine in the future?

Point-of-care biosensors are in development, but NAD+ testing is not yet routine clinical practice.

Key Research Facts

1

Liquid chromatography-mass spectrometry (LC-MS/MS) is the gold standard for quantifying NAD+ and related metabolites.

Strong Evidence

Trammell SA & Brenner C, Curr Opin Biotechnol — doi:10.1016/j.copbio.2015.08.003

2

Blood NAD+ levels may not accurately reflect tissue-specific NAD+ concentrations in brain, liver, or muscle.

Strong Evidence

Liu L et al., Cell Metab — doi:10.1016/j.cmet.2018.03.018

3

NAD+ levels in healthy adults decline approximately 1–2% per year after age 30–40.

Moderate Evidence

Massudi H et al., PLoS One — doi:10.1371/journal.pone.0042357

4

31P-MRS can non-invasively measure the NAD+/NADH ratio in living human brain tissue.

Strong Evidence

Zhu XH et al., J Magn Reson Imaging — doi:10.1002/jmri.24964

5

Standardized clinical reference ranges for human NAD+ levels have not been established.

Strong Evidence

Clement J et al., Cell Rep — doi:10.1016/j.celrep.2019.01.043

6

NAD+ degrades rapidly in biological samples, making pre-analytical sample handling critical for accurate measurement.

Strong Evidence

Clement J et al., Cell Rep — doi:10.1016/j.celrep.2019.01.043

7

Comprehensive NAD+ metabolomics can simultaneously quantify >8 related metabolites from a single blood sample.

Strong Evidence

Liu L et al., Cell Metab — doi:10.1016/j.cmet.2018.03.018

8

Consumer-level NAD+ tests using dried blood spots have lower analytical accuracy than clinical mass spectrometry.

Moderate Evidence

Clement J et al., Cell Rep — doi:10.1016/j.celrep.2019.01.043

9

Inflammatory markers (CRP, IL-6) are inversely correlated with NAD+ levels through CD38-mediated NAD+ degradation.

Strong Evidence

Covarrubias AJ et al., Nat Rev Mol Cell Biol — doi:10.1038/s41580-020-00313-x

10

Point-of-care NAD+ biosensor devices are in development but not yet commercially available for clinical use.

Moderate Evidence

Covarrubias AJ et al., Nat Rev Mol Cell Biol — doi:10.1038/s41580-020-00313-x

Continue Your Research

Explore related topics and take the next step in your cellular health journey.

Citations & External Resources

Review

Cell Reports — NAD+ measurement methods

Review

NIH — NAD+ biomarkers

Review

Analytical Chemistry — Mass spectrometry NAD+ quantification

Review

Cell Metabolism — NAD+ metabolomics

Review

Nat Rev Mol Cell Biol — NAD+ metabolism review

Your Cells Replace Themselves Every 7–10 Years. The Question Is: With What?

The raw materials you give your body today determine the quality of every new cell. Make each one count.

Related Reading

References (3)

Written by

ReCellence™ Editorial Team

Health Content Specialists

Medically reviewed by

Medical Review Board

MD, PhD

Last updated: March 8, 2026

Last medical review: March 8, 2026